Mitochondrial-lonidamine activates the generation of ROS in lung cancer cells, which leads to the inactivation of the Akt/mTOR/p70S6K signaling pathways and autophagic cell death (Cheng et al., 2019). Here, AKT1 is linked to lung cancer.